Exactitude Consultancy
Home Report Store Categories Primary Research Consulting Services Blog Contact us About Us Terms & Conditions Privacy Policy

Genotyping Assay Market

Apr 2023

Base Year Value ()

x.x %
x.x %

CAGR ()

x.x %
x.x %

Forecast Year Value ()

x.x %
x.x %

Historical Data Period

Largest Region

Forecast Period

Mercado de ensayos de genotipado por tecnología (PCR, electroforesis capilar, microarrays, secuenciación, espectrometría de masas), por producto (instrumentos, reactivos y kits), por aplicaciones (farmacogenómica, diagnóstico, genética animal, biotecnología agrícola) y región, tendencias globales y pronóstico de 2023 a 2029

Instant access to hundreds of data points and trends

  • Market estimates from 2014-2029
  • Competitive analysis, industry segmentation, financial benchmarks
  • Incorporates SWOT, Porter's Five Forces and risk management frameworks
  • PDF report or online database with Word, Excel and PowerPoint export options
  • 100% money back guarantee

Descripción general del mercado de ensayos de genotipificación


Se espera que el mercado de ensayos de genotipificación crezca a una tasa anual compuesta del 21,09 % entre 2022 y 2029. Se espera que alcance más de 55 900 millones de dólares en 2029 desde los 11 100 millones de dólares en 2020.

La genotipificación es el proceso de determinar la secuencia de ADN en una ubicación particular dentro de un gen . Las especies y los individuos dentro de la misma especie tienen diferentes secuencias de ADN. El polimorfismo de un solo nucleótido (SNP), la inserción y deleción (indel) y varios números de copias de genes son las causas de las variaciones genéticas. Estas diferencias genéticas determinan las cualidades fenotípicas de un individuo. Al comparar una secuencia de ADN con la de otra muestra o una secuencia de referencia, un ensayo de genotipificación puede identificar variaciones genéticas.


Para estudiar la genética de poblaciones, las asociaciones de enfermedades, los atributos agrícolas y los microbios, los ensayos de genotipificación son esenciales. La reacción en cadena de la polimerasa (PCR), la electroforesis, la micromatriz y la MALDI-TOF se pueden utilizar en ensayos de genotipificación.


Mediante el análisis de la secuencia de ADN de una persona mediante ensayos biológicos y su comparación con la secuencia de otra persona o una secuencia de referencia, el proceso de genotipificación identifica variaciones en la composición genética de un individuo (genotipo). Esta prueba permite determinar claramente los alelos que una persona heredó de sus padres. La genotipificación es la práctica de utilizar secuencias de ADN para identificar poblaciones biológicas mediante técnicas moleculares. Por lo general, no implica definir los genes de una persona.






















































ATRIBUTODETALLES
Periodo de estudio2020-2029
Año base2021
Año estimado2022
Año pronosticado2022-2029
Periodo histórico2018-2020
UnidadValor (miles de millones de USD)
SegmentaciónPor tecnología, por producto, por aplicación, por región
Por tecnología

 


Por producto

 


  • Instrumentos

  • Reactivos y kits

  • Bioinformática

  • Servicios de genotipificación


Por aplicaciones

 


  • Farmacogenómica

  • Diagnóstico

  • Genética animal

  • Biotecnología agrícola


Por región

 


  • América del norte

  • Asia Pacífico

  • Europa

  • Sudamerica

  • Oriente Medio, Asia y África



Los avances tecnológicos, la flexibilidad operativa y la introducción de pruebas multiparamétricas han contribuido a la miniaturización, la automatización y la reducción de los costos totales. Todo esto ha contribuido a la conveniencia y mayor utilidad de la secuenciación de ADN, lo que ha permitido a los médicos centrarse en decisiones más importantes, como la elección y priorización de los objetivos del tratamiento a través de varios estudios de genotipado. Esto ha mejorado la aplicación de la PCR, la secuenciación, la electroforesis capilar y los microarrays en áreas como la investigación clínica y el desarrollo de medicamentos. Además, la secuenciación rápida y precisa ha sido posible gracias a los avances tecnológicos en la secuenciación de ADN, como la secuenciación de próxima generación (NGS), que ha aumentado enormemente la productividad.


Las principales razones que impulsan la expansión del mercado incluyen la creciente importancia de la genotipificación en el desarrollo de fármacos, la creciente conciencia de la medicina personalizada, los avances tecnológicos, la caída de los costos de la secuenciación del ADN y la creciente importancia de los proyectos de secuenciación. Otros factores que se prevé que impulsen la demanda del mercado en todo el mundo incluyen la creciente demanda de soluciones bioinformáticas para el análisis de datos y un aumento en la prevalencia de enfermedades genéticas como la hiperplasia suprarrenal congénita, el albinismo, el síndrome de Down y muchas otras.


Dado que el procesamiento y la gestión de los datos de genotipado requieren un alto nivel de competencia técnica, la falta de especialistas experimentados, en particular en los países en desarrollo, podría obstaculizar la expansión del mercado. En la actualidad, los países en desarrollo cuentan con un número comparativamente pequeño de profesionales y especialistas. Además, los equipos de genotipado son caros, ya que tienen características y capacidades sofisticadas. Las empresas farmacéuticas y los centros de investigación necesitan estos sistemas en grandes cantidades, lo que requiere inversiones considerables para comprar numerosos y costosos instrumentos de genotipado. El aumento general del costo total de propiedad de estos instrumentos se debe a los costos de mantenimiento, así como a una serie de otros costos indirectos, incluidos los costos de las muestras y la mano de obra.

La farmacogenómica, la investigación diagnóstica, el tratamiento individualizado y la ciencia forense son algunos de los usos de las tecnologías de genotipado. La técnica también es apropiada para una variedad de necesidades veterinarias, pruebas de seguridad y calidad de los alimentos y condiciones ambientales en entornos rurales e industriales. La creciente incidencia de enfermedades y la necesidad de mejores opciones de tratamiento han creado mercados para el diagnóstico humano y la farmacogenómica que tienen un potencial considerable de marcadores en este momento. Además, estos segmentos necesitan un análisis de genotipado rápido y extenso.


Durante la crisis de la COVID-19, el mercado de la genotipificación experimentó un auge. Se han encontrado variaciones genéticas del virus de la COVID-19 mediante la genotipificación de polimorfismos de un solo nucleótido (SNP). Las variantes preocupantes (VOC) asociadas con el virus SARS-CoV-2 podrían hacerlo más contagioso y reducir la eficacia de las vacunas contra la COVID-19 a medida que el virus continúa mutando. Los médicos de todo el mundo comenzaron a genotipar las variantes del SARS-CoV-2 como respuesta. La necesidad de iniciativas de investigación basadas en la genotipificación para crear diagnósticos, vacunas y tratamientos contra la COVID-19 se intensificó como resultado de la pandemia de la COVID-19.


La genotipificación es la base de las pruebas de diagnóstico en la población, ya que las enfermedades son difíciles de diagnosticar clínicamente. Un factor impulsor importante puede ser el creciente uso de pruebas genéticas prenatales para detectar anomalías cromosómicas en los fetos.




[título id="attachment_14521" align="aligncenter" width="1920"]Genotyping Assay Market | Exactitude Consultancy
Mercado de ensayos de genotipado | Exactitude Consultancy
[/subtítulo]

Frequently Asked Questions

What is the worth of Genotyping Assay market?

The genotyping assay market is expected to grow at 21.09% CAGR from 2022 to 2029. It is expected to reach above USD 55.9 billion by 2029 from USD 11.1 billion in 2020.

• What is the size of the North America genotyping assay industry?

North America held more than 34% of the Genotyping Assay market revenue share in 2021 and will witness expansion in the forecast period.

• What are some of the market's driving forces?

Technological advances, operational flexibility, and the introduction of multi-parameter testing have all contributed to miniaturization, automation, and lower total costs. All of this has contributed to the convenience and increased utility of DNA sequencing, freeing doctors to focus on more important choices like choosing and prioritizing treatment targets through various genotyping studies. This has improved the application of PCR, sequencing, capillary electrophoresis, and microarrays in areas such as clinical research and medication development.

• Which are the top companies to hold the Market Share in Genotyping Assay market?

Key companies in the global market include Illumina, thermo fisher scientific, agilent technologies, Danaher corporation, roche diagnostics, GE healthcare, PerkinElmer, integrated DNA technologies, Bio-Rad laboratories, GENEWIZ.

• What is the leading Application of genotyping assay market?

By applications, the genotyping market has applications like pharmacogenomics, diagnostics and personalized medicine, animal genetics, and agricultural biotechnology. The market's highest share is anticipated to belong to the diagnostics and personalized medication segment.

• Which is the largest regional Market for Genotyping Assay market?

North America is the largest market in 2021 accounted for 34% revenue generation of worldwide sales. It is due to advancement in technology and advancement in manufacturing is the reason behind this. During the time of forecasting, North America is anticipated to have the greatest market share in the worldwide genotyping market. High healthcare costs, presence of cutting-edge healthcare infrastructure, highly developed healthcare systems in the US and Canada, numerous genotyping-based R&D projects, presence of a large number of top genotyping manufacturers in the region, growing demand from pharmaceutical companies for genotyping products, rising government investment, increasing adoption of technologically advanced genotyping products, high healthcare expenditures.

Genotyping Assay Market Segment Analysis

The genotyping assay market is segmented based on technology, product and applications and Region, Global trends and forecast.

By segments, the market is bifurcated into by technology (PCR, capillary electrophoresis, microarrays, sequencing, mass spectrometry), by product (instruments, reagents and kits), by applications (pharmacogenomics, diagnostics, animal genetics, agricultural biotechnology) and region, global trends and forecast.

By technology, the genotyping market is divided into categories based on technology including mass spectrometry, polymerase chain reaction (PCR), capillary electrophoresis, sequencing, matrix-assisted laser desorption/ionization-time of flight (Maldi-ToF), and microarrays. The polymerase chain reaction (PCR) market category is anticipated to account for the biggest market share.  the same segment is anticipated to have the highest CAGR.

Based on products, the genotyping market has products like instruments, reagents & kits, bioinformatics, and genotyping services based on product and service. Within the product & service segment during the course of the projection period, reagents and kits are expected to grow at the highest CAGR. The high growth is attributed to the availability of a wide range of reagents, the increasing demand for reagents as a result of the increased number of genotyping tests conducted globally, and the relatively low capital investment required to adopt reagents and kits for genotyping in hospitals and diagnostic labs.

By applications, the genotyping market has applications like pharmacogenomics, diagnostics and personalized medicine, animal genetics, and agricultural biotechnology. The market's highest share is anticipated to belong to the diagnostics and personalized medication segment.

[caption id="attachment_14527" align="aligncenter" width="1920"]Genotyping Assay Market | Exactitude Consultancy
Genotyping Assay Market | Exactitude Consultancy
[/caption]

Genotyping Assay Market Players

Key companies in the global market include Illumina, thermo fisher scientific, agilent technologies, Danaher corporation, roche diagnostics, GE healthcare, PerkinElmer, integrated DNA technologies, Bio-Rad laboratories, GENEWIZ.

06-02-2023: - Thermo Fisher Scientific, the world leader in serving science, and Celltrio, a leading manufacturer of robotics-based solutions for the life sciences industry, have announced their collaboration to bring a fully automated Genotyping Assay system to biotherapeutics customers. 24-01-2023: - Thermo Fisher Scientific partners with AstraZeneca to develop solid tissue and blood-based companion diagnostic test for tagrisso.

Who Should Buy? Or Key stakeholders

  • Genotyping Assay Suppliers
  • Hospitals
  • Laboratories
  • Vaccines lab
  • Investors
  • Research
  • Others

Genotyping Assay Market Regional Analysis

The Genotyping Assay market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

  • North America: includes the US, Canada, Mexico
  • Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
  • Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
  • South America: includes Brazil, Argentina and Rest of South America
  • Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

During the projected period, North America is the largest market in 2021 accounted for 34% revenue generation of worldwide sales. It is due to advancement in technology and advancement in manufacturing is the reason behind this.

During the time of forecasting, North America is anticipated to have the greatest market share in the worldwide genotyping market. High healthcare costs, presence of cutting-edge healthcare infrastructure, highly developed healthcare systems in the US and Canada, numerous genotyping-based R&D projects, presence of a large number of top genotyping manufacturers in the region, growing demand from pharmaceutical companies for genotyping products, rising government investment, increasing adoption of technologically advanced genotyping products, high healthcare expenditures.

During the anticipated period, the Genotyping Assay Market is anticipated to develop at the fastest rate in Asia Pacific. The existence of growing economies and the most populous nations in the globe, such as China and India, are factors that have contributed to the market expansion in the area.

[caption id="attachment_14529" align="aligncenter" width="1920"]Genotyping Assay Market | Exactitude Consultancy
Genotyping Assay Market | Exactitude Consultancy
[/caption]

Key Market Segments: Genotyping Assay Market

Genotyping Assay Market by Technology, 2020-2029, (USD Billion)
  • PCR
  • Capillary Electrophoresis
  • Microarrays
  • Sequencing
  • Mass Spectrometry
Genotyping Assay Market by Product, 2020-2029, (USD Billion)
  • Instruments
  • Reagents And Kits
  • Bioinformatics
  • Genotyping Services
Genotyping Assay Market by Applications, 2020-2029, (USD Billion)
  • Pharmacogenomics
  • Diagnsotics
  • Animal Genetics
  • Agricultural Biotechnology
Genotyping Assay Market by Region, 2020-2029, (USD Billion)
  • North America
  • Asia Pacific
  • Europe
  • South America
  • Middle East And Africa
Important Countries In All Regions Are Covered.

Exactitude Consultancy Services Key Objectives:

  • Increasing sales and market share
  • Developing new technology
  • Improving profitability
  • Entering new markets
  • Enhancing brand reputation

Key Question Answered

  • What is the expected growth rate of the genotyping assay market over the next 7 years?
  • Who are the major players in the genotyping assay market and what is their market share?
  • What are the end-user industries driving demand for market and what is their outlook?
  • What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
  • How is the economic environment affecting the genotyping assay market, including factors such as interest rates, inflation, and exchange rates?
  • What is the expected impact of government policies and regulations on the genotyping assay market?
  • What is the current and forecasted size and growth rate of the global genotyping assay market?
  • What are the key drivers of growth in the genotyping assay market?
  • Who are the major players in the market and what is their market share?
  • What are the distribution channels and supply chain dynamics in the genotyping assay market?
  • What are the technological advancements and innovations in the genotyping assay market and their impact on product development and growth?
  • What are the regulatory considerations and their impact on the market?
  • What are the challenges faced by players in the genotyping assay market and how are they addressing these challenges?
  • What are the opportunities for growth and expansion in the genotyping assay market?
  • What are the service offerings and specifications of leading players in the market?
  • What is the pricing trend of genotyping assays in the market and what is the impact of raw material prices on the price trend?

  1. INTRODUCCIÓN

    1. DEFINICIÓN DE MERCADO

    2. SEGMENTACIÓN DEL MERCADO

    3. CRONOGRAMAS DE INVESTIGACIÓN

    4. SUPUESTOS Y LIMITACIONES



  2. METODOLOGÍA DE LA INVESTIGACIÓN

    1. MINERÍA DE DATOS

      1. INVESTIGACIÓN SECUNDARIA

      2. INVESTIGACIÓN PRIMARIA

      3. ASESORAMIENTO DE EXPERTOS EN LA MATERIA



    2. CONTROLES DE CALIDAD

      1. REVISIÓN FINAL



    3. TRIANGULACIÓN DE DATOS

      1. ENFOQUE DE ABAJO HACIA ARRIBA

      2. ENFOQUE DE ARRIBA HACIA ABAJO

      3. FLUJO DE INVESTIGACIÓN



    4. FUENTES DE DATOS



  3. RESUMEN EJECUTIVO

  4. PANORAMA DEL MERCADO

    1. PERSPECTIVAS DE LOS ENSAYOS DE GENOTIPACIÓN A NIVEL MUNDIAL

      1. IMPULSORES DEL MERCADO

      2. RESTRICCIONES DEL MERCADO

      3. OPORTUNIDADES DE MERCADO



    2. IMPACTO DEL COVID-19 EN EL MERCADO DE ENSAYOS DE GENOTIPACIÓN

    3. MODELO DE LAS CINCO FUERZAS DE PORTER

      1. AMENAZA DE NUEVOS INGRESANTES

      2. AMENAZA DE SUSTITUTOS

      3. PODER DE NEGOCIACIÓN DE LOS PROVEEDORES

      4. PODER DE NEGOCIACIÓN DE LOS CLIENTES

      5. GRADO DE COMPETENCIA



    4. ANÁLISIS DE LA CADENA DE VALOR DE LA INDUSTRIA



  5. MERCADO GLOBAL DE ENSAYOS DE GENOTIPACIÓN POR TECNOLOGÍA (MIL MILLONES DE USD) 2020-2029

    1. PCR

    2. ELECTROFORESIS CAPILAR

    3. MICROARREGLOS

    4. SECUENCIACIÓN

    5. ESPECTROMETRÍA DE MASAS



  6. MERCADO MUNDIAL DE ENSAYOS DE GENOTIPACIÓN POR PRODUCTO (MIL MILLONES DE USD) 2020-2029

    1. INSTRUMENTOS

    2. REACTIVOS Y KITS

    3. BIOINFORMÁTICA

    4. SERVICIOS DE GENOTIPACIÓN



  7. MERCADO GLOBAL DE ENSAYOS DE GENOTIPACIÓN POR APLICACIÓN (MIL MILLONES DE USD) 2020-2029

    1. FARMACOGENOMICA

    2. DIAGNÓSTICO

    3. GENÉTICA ANIMAL

    4. BIOTECNOLOGÍA AGRÍCOLA



  8. MERCADO MUNDIAL DE ENSAYOS DE GENOTIPACIÓN POR REGIÓN (MIL MILLONES DE USD) 2020-2029

    1. AMÉRICA DEL NORTE

      1. A NOSOTROS

      2. CANADÁ

      3. MÉXICO



    2. SUDAMERICA

      1. BRASIL

      2. ARGENTINA

      3. COLOMBIA

      4. RESTO DE SUDAMÉRICA



    3. EUROPA

      1. ALEMANIA

      2. Reino Unido

      3. FRANCIA

      4. ITALIA

      5. ESPAÑA

      6. RUSIA

      7. RESTO DE EUROPA



    4. ASIA PACÍFICO

      1. INDIA

      2. PORCELANA

      3. JAPÓN

      4. COREA DEL SUR

      5. AUSTRALIA

      6. ASIA SUDESTE

      7. RESTO DE ASIA PACÍFICO



    5. ORIENTE MEDIO Y ÁFRICA

      1. Emiratos Árabes Unidos

      2. ARABIA SAUDITA

      3. SUDÁFRICA

      4. RESTO DE ORIENTE MEDIO Y ÁFRICA







  1. PERFILES DE EMPRESAS* (DESCRIPCIÓN GENERAL DEL NEGOCIO, RESEÑA DE LA EMPRESA, PRODUCTOS OFRECIDOS, DESARROLLOS RECIENTES)

    1. ILUMINACIÓN

    2. TERMO FISHER CIENTÍFICO

    3. TECNOLOGÍAS AGILENT

    4. CORPORACIÓN DANHER

    5. DIAGNÓSTICO ROCHE

    6. ATENCIÓN MÉDICA GE

    7. PERKINELMER

    8. TECNOLOGÍAS DE ADN INTEGRADAS

    9. LABORATORIOS BIO-RAD

    10. GENEWIZ *EL LISTADO DE EMPRESAS ES ORIENTATIVO




LISTA DE TABLAS


TABLE 1 GLOBAL GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 2 GLOBAL GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 3 GLOBAL GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 4 GLOBAL GENOTYPING ASSAY MARKET BY REGION (USD BILLION) 2020-2029

TABLE 5 NORTH AMERICA GENOTYPING ASSAY MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 6 NORTH AMERICA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 7 NORTH AMERICA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 8 NORTH AMERICA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 9 US GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 10 US GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 11 US GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 12 CANADA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 13 CANADA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 14 CANADA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 15 MEXICO GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 16 MEXICO GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 17 MEXICO GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 18 SOUTH AMERICA GENOTYPING ASSAY MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 19 SOUTH AMERICA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 20 SOUTH AMERICA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 21 SOUTH AMERICA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 22 BRAZIL GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 23 BRAZIL GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 24 BRAZIL GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 25 ARGENTINA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 26 ARGENTINA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 27 ARGENTINA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 28 COLOMBIA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 29 COLOMBIA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 30 COLOMBIA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 31 REST OF SOUTH AMERICA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 32 REST OF SOUTH AMERICA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 33 REST OF SOUTH AMERICA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 34 ASIA-PACIFIC GENOTYPING ASSAY MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 35 ASIA-PACIFIC GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 36 ASIA-PACIFIC GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 37 ASIA-PACIFIC GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 38 INDIA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 39 INDIA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 40 INDIA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 41 CHINA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 42 CHINA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 43 CHINA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 44 JAPAN GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 45 JAPAN GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 46 JAPAN GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 47 SOUTH KOREA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 48 SOUTH KOREA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 49 SOUTH KOREA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 50 AUSTRALIA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 51 AUSTRALIA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 52 AUSTRALIA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 53 SOUTH-EAST ASIA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 54 SOUTH-EAST ASIA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 55 SOUTH-EAST ASIA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 56 REST OF ASIA PACIFIC GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 57 REST OF ASIA PACIFIC GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 58 REST OF ASIA PACIFIC GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 59 EUROPE GENOTYPING ASSAY MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 60 ASIA-PACIFIC GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 61 ASIA-PACIFIC GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 62 ASIA-PACIFIC GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 63 GERMANY GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 64 GERMANY GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 65 GERMANY GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 66 UK GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 67 UK GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 68 UK GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 69 FRANCE GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 70 FRANCE GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 71 FRANCE GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 72 ITALY GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 73 ITALY GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 74 ITALY GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 75 SPAIN GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 76 SPAIN GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 77 SPAIN GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 78 RUSSIA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 79 RUSSIA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 80 RUSSIA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 81 REST OF EUROPE GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 82 REST OF EUROPE GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 83 REST OF EUROPE GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 84 MIDDLE EAST AND AFRICA GENOTYPING ASSAY MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 85 MIDDLE EAST AND AFRICA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 86 MIDDLE EAST AND AFRICA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 87 MIDDLE EAST AND AFRICA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 88 UAE GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 89 UAE GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 90 UAE GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 91 SAUDI ARABIA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 92 SAUDI ARABIA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 93 SAUDI ARABIA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 94 SOUTH AFRICA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 95 SOUTH AFRICA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 96 SOUTH AFRICA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

TABLE 97 REST OF MIDDLE EAST AND AFRICA GENOTYPING ASSAY MARKET BY TYPE (USD BILLION) 2020-2029

TABLE 98 REST OF MIDDLE EAST AND AFRICA GENOTYPING ASSAY MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 99 REST OF MIDDLE EAST AND AFRICA GENOTYPING ASSAY MARKET BY PRODUCT (USD BILLION) 2020-2029

LIST OF FIGURES


FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL GENOTYPING ASSAY BY TECHNOLOGY, USD BILLION, 2020-2029

FIGURE 9 GLOBAL GENOTYPING ASSAY BY PRODUCT, USD BILLION, 2020-2029

FIGURE 10 GLOBAL GENOTYPING ASSAY BY APPLICATION, USD BILLION, 2020-2029

FIGURE 11 GLOBAL GENOTYPING ASSAY BY REGION, USD BILLION, 2020-2029

FIGURE 12 GLOBAL GENOTYPING ASSAY BY TECHNOLOGY, USD BILLION, 2021

FIGURE 13 GLOBAL GENOTYPING ASSAY BY PRODUCT, USD BILLION, 2021

FIGURE 14 GLOBAL GENOTYPING ASSAY BY APPLICATION, USD BILLION, 2021

FIGURE 15 GLOBAL GENOTYPING ASSAY BY REGION, USD BILLION, 2021

FIGURE 16 PORTER’S FIVE FORCES MODEL

FIGURE 17 MARKET SHARE ANALYSIS

FIGURE 18 ILLUMINA: COMPANY SNAPSHOT

FIGURE 19 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

FIGURE 20 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT

FIGURE 21 DANHER CORPORATION: COMPANY SNAPSHOT

FIGURE 22 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT

FIGURE 23 GE HEALTHCARE: COMPANY SNAPSHOT

FIGURE 24 PERKINELMER: COMPANY SNAPSHOT

FIGURE 25 INTEGRATED DNA TECHNOLOGIES: COMPANY SNAPSHOT

FIGURE 26 BIO-RAD LABORATORIES: COMPANY SNAPSHOT

DOWNLOAD FREE SAMPLE REPORT

Kindly share your specific requirement (if any)
6365

License Type

Single User

US$ 3499

Multi User

US$ 4499

Corporate User

US$ 5499

Get Sample to Email

SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

Proactive

We manage our resources 24/7 to identify issues and address them before they become problems

Quality & Reliability

We are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach

6 Major regions and 40+ countries level analysis accomplished

Competitive Pricing

Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

In-Depth Database

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Customer Support

Complete pre and post sales support.

Safe & Secure

Safe & Secure

Complete secure payment process.